
Proceedings Paper
Quantitative fluorescence imaging enabled by spatial frequency domain optical-property mapping in the sub-diffusive regime for surgical guidanceFormat | Member Price | Non-Member Price |
---|---|---|
$17.00 | $21.00 |
Paper Abstract
Intraoperative fluorescence guidance enables maximum safe resection of, for example, glioblastomas by providing
surgeons with real-time tumor optical contrast. Specifically, 5-aminolevulinic acid (ALA)-induced protoporphyrin IX
(PpIX) fluorescence guided resection can improve surgical outcomes by better defining tumor margins and identifying
satellite tumor foci. However, visual assessment of PpIX fluorescence is subjective and limited by the distorting effects
of light attenuation (absorption and scattering) by tissue and background tissue autofluorescence. We have previously
shown, using a point fluorescence-reflectance fiberoptic probe, that non-invasive measurement of the absolute PpIX
concentration, [PpIX], further improves sensitivity and specificity, leading to the demonstration that the technique can
also detect low-grade gliomas as well as otherwise undetectable residual tumor foci in high-grade disease. Here, we
extend this approach to wide-field quantitative fluorescence imaging (qFI) by implementing spatial frequency domain
imaging (SFDI) to recover the tissue optical absorption and transport scattering coefficients across the field of view. We
report on the performance of this approach to determine the intrinsic fluorescence intensity in tissue-simulating
phantoms in both the fully diffusive (i.e. scatter-dominated) and sub-diffusive (low transport albedo) regimes, for which
higher spatial frequencies are used. The performance of qFI is compared to a Born- normalization correction scheme, as
well as to the values obtained using the fiberoptic probe on homogeneous tissue phantoms containing PpIX.
Paper Details
Date Published: 4 March 2015
PDF: 15 pages
Proc. SPIE 9311, Molecular-Guided Surgery: Molecules, Devices, and Applications, 93110C (4 March 2015); doi: 10.1117/12.2080205
Published in SPIE Proceedings Vol. 9311:
Molecular-Guided Surgery: Molecules, Devices, and Applications
Brian W. Pogue; Sylvain Gioux, Editor(s)
PDF: 15 pages
Proc. SPIE 9311, Molecular-Guided Surgery: Molecules, Devices, and Applications, 93110C (4 March 2015); doi: 10.1117/12.2080205
Show Author Affiliations
Mira Sibai, Univ. of Toronto (Canada)
Princess Margaret Cancer Ctr., Univ. Health Network (Canada)
Israel Veilleux, Princess Margaret Cancer Ctr., Univ. Health Network (Canada)
Jonathan T. Elliott, Dartmouth College and Hitchcock Medical Ctr. (Canada)
Princess Margaret Cancer Ctr., Univ. Health Network (Canada)
Israel Veilleux, Princess Margaret Cancer Ctr., Univ. Health Network (Canada)
Jonathan T. Elliott, Dartmouth College and Hitchcock Medical Ctr. (Canada)
Frederic Leblond, École Polytechnique de Montreal (Canada)
David W. Roberts, Univ. of Toronto (Canada)
Princess Margaret Cancer Ctr., Univ. Health Network (Canada)
Brian C. Wilson, Univ. of Toronto (Canada)
Princess Margaret Cancer Ctr., Univ. Health Network (Canada)
David W. Roberts, Univ. of Toronto (Canada)
Princess Margaret Cancer Ctr., Univ. Health Network (Canada)
Brian C. Wilson, Univ. of Toronto (Canada)
Princess Margaret Cancer Ctr., Univ. Health Network (Canada)
Published in SPIE Proceedings Vol. 9311:
Molecular-Guided Surgery: Molecules, Devices, and Applications
Brian W. Pogue; Sylvain Gioux, Editor(s)
© SPIE. Terms of Use
